ÂÜÀòÂÒÂ×

Peter Emtage, Ph.D., is an accomplished professional in the biotechnology sector, currently serving as the Chief Executive Officer at Santa Ana Bio, Inc. since June 2021, while also holding a position as Venture Partner at Versant Ventures since October 2020. Prior to these roles, Peter Emtage was the Global Head of Cell Therapy Research at Kite Pharma from February 2018 to October 2020. Additionally, Peter Emtage contributed as the Chief Scientific Officer at Cell Design Labs from March 2016 to February 2018, a company known for developing innovative cell-based therapies aimed at treating cancer and other severe diseases by harnessing the immune system's capabilities.